Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apo B | cis | Discovery | rs520354 | 2:21,259,612 | A/G | 0.47 | 996 | 0.303 | 0.042 | 6.9×10-13 | 1.110 | 6.6×10-13 | 2.5×10-12 |
Apo B | cis | Replication | rs679899 | 2:21,250,914 | A/G | 0.47 | 337 | -0.219 | 0.068 | 0.001 | -1.110 | 0.001 | 0.006 |
Target (abbrv.) | Apo B |
Target (full name) | Apolipoprotein B |
Somalogic ID (Sequence ID) | SL000020 (2797-56_2) |
Entrez Gene Symbol | APOB |
UniProt ID | P04114 |
UniProt Comment |
|
Targeted by drugs (based on IPA annotation) |
|
Biomarker applications (based on IPA annotation) |
|
Wiki Pathways |
|
Pathway Interaction Database |
|
Reactome |
|
All locus annotations are based on the sentinel SNP (rs520354) and 3 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
Genes hit or close-by |
|
Trait | P | Study | Source |
---|---|---|---|
LDL cholesterol | 4.4×10-52 | 24097068 (PMID) | Supplemental file |
Triglycerides | 3.8×10-37 | 24097068 (PMID) | Supplemental file |
Total cholesterol | 1.1×10-33 | 20686565 (PMID) | GRASP2 nonQTL |
HDL cholesterol | 2.3×10-14 | 24097068 (PMID) | Supplemental file |
Serum ratio of (2-linoleoylglycerophosphoethanolamine*)/(creatine) | 2.9×10-5 | 21886157 (PMID) | GRASP2 metabQTL |
Lipoproteins, ldl | 9×10-5 | pha002902 (dbGaP) | dbGaP via SNiPA |
Serum concentration of 1,7-dimethylurate | 1.6×10-4 | 21886157 (PMID) | GRASP2 metabQTL |
Transmission distortion | 3.9×10-4 | 22377632 (PMID) | GRASP2 nonQTL |